is a Consultant Gynaecological Oncologist at Barts and the Royal London Hospital, and a Clinical Senior Lecturer at Barts Cancer Institute, Queen Mary University of London, UK.
He has served as the president of the European Network of Young Gynaecological Oncologists (ENYGO) as well as a member of the European Society of Gynaecological Oncology (ESGO) council from 2011 to 2013. He completed a PhD in gynaecological oncology at University College London in 2013 and subspecialty training in Gynaecological Oncology in 2014.
Ranjit’s research interests include P4 (Predictive, Preventive, Participatory and Personalised) medicine and Precision medicine approaches for ovarian and endometrial cancer. This includes risk prediction, screening and prevention of ovarian & endometrial cancer, population based approaches to genetic testing, risk stratification and targeted surgical prevention strategies for ovarian cancer; as well as management of familial gynaecological cancer. He is the research lead and acting PI on the GCaPPS trial, which evaluated population testing for BRCA1/BRCA2 mutations in the London Jewish population. He has presented a number of papers and published on his areas of research interest. His clinical interests include management of familial gynaecological cancer, ultra-radical debulking surgery for ovarian cancer & advanced complex laparoscopic surgery for gynaecological cancers. He leads the familial gynaecological service and the gynaecological oncology clinical trials group at Bartshealth NHS Trust, London, UK. He has been actively involved in and undertaken a number of initiatives related to training in gynaecological oncology.